All manuscripts
Publications CAR T Cells G-Rex®24 Well Plate

Modular microfluidic device for intensified CAR T cell expansion

Journal Biochemical Engineering Journal

Share
8 pages Modular microfluidic device for intensified CAR T cell expansion

Overview

This study compared a perfused microfluidic device with a G-Rex® 24-well plate over four days of T cell and anti-CD19 CAR T cell culture. For the CAR T cells, the device reached 56.5 × 10^6 viable cells per mL against 3.14 × 10^6, but fewer in total, 14.1 × 10^6 against 25.1 × 10^6.

What this paper found

A compact perfused microfluidic culture device (µCCD) expanded primary T cells and anti-CD19 CAR T cells to much higher cell concentrations than a 24-well G-Rex® control, though with fewer total cells. Both systems were inoculated with one million cells, a density of 0.5 × 10⁶ cells per cm², and cultured for four days. CAR T cells reached 56.5 × 10⁶ viable cells per mL in the µCCD versus 3.14 × 10⁶ in the G-Rex®, with 14.1 × 10⁶ versus 25.1 × 10⁶ total viable cells. The µCCD consumed 46.8 mL of medium per device against 14 mL per G-Rex® well. Cytotoxicity against NALM6 targets was comparable, and µCCD cultures contained a higher proportion of central memory CD8 cells.

Note: Each cell type came from a single donor, with technical replicates; the authors state that additional independent donors are needed to confirm the findings.

However, both primary T-cell and CAR T-cell cultures yielded fewer total viable cells in the µCCD than in the G-Rex®, highlighting the distinction between high volumetric cell concentration and absolute cell yield. — Jorge Aranda Hernandez, Oleksandra Derevianko, Pierre Springuel, Pedro Silva Couto, Jan-Angelus Meyer, Rainer Krull, Qasim Rafiq, Nicolas Szita, Biochemical Engineering Journal

Study details

Authors
Jorge Aranda Hernandez, Oleksandra Derevianko, Pierre Springuel, Pedro Silva Couto, Jan-Angelus Meyer, Rainer Krull, Qasim Rafiq, Nicolas Szita
Institution
Department of Biochemical Engineering, University College London (UCL), London, United Kingdom · Institute of Biochemical Engineering, Technische Universität Braunschweig, Braunschweig, Germany · Center of Pharmaceutical Engineering, Technische Universität Braunschweig, Braunschweig, Germany
Journal
Biochemical Engineering Journal
Year
2026
G-Rex® model(s)
G-Rex®24 Well Plate
Cell type(s)
CAR T Cells
Application area
Hematologic malignancy
Study phase
Preclinical

How G-Rex® was used

The 24-well G-Rex® served as the benchmark culture for both primary T cells and anti-CD19 CAR T cells. Wells were inoculated with 1 × 10⁶ cells in 250 µL of suspension plus 7.75 mL of complete RPMI, giving an 8 mL working volume and 0.5 × 10⁶ cells per cm². Cultures were spiked with IL-2 and 6 mL of fresh medium was exchanged after 2 days, then cells were harvested manually on day 4. Primary T cells reached 49.8 × 10⁶ viable cells (6.22 × 10⁶ per mL) and CAR T cells 25.1 × 10⁶ (3.14 × 10⁶ per mL).

Explore related

Full citation

Aranda Hernandez J, Derevianko O, Springuel P, et al. Modular microfluidic device for intensified CAR T cell expansion. Biochem Eng J. 2027;237:110440.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →